Global Atrial Fibrillation Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Atrial Fibrillation Market is expected to grow from USD 5,263.26 Million in 2018 to USD 12,289.24 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.87%.
The positioning of the Global Atrial Fibrillation Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Atrial Fibrillation Market including are Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, Acesion Pharma ApS, AFreeze GmbH, AuriGen Medical., BIOTRONIK SE & CO. KG, CardioFocus, Inc., Koninklijke Philips N.V, MicroPort Scientific Corp, Siemens AG, St. Jude Medical, Inc., and Stroke Foundation.
On the basis of Device, the Global Atrial Fibrillation Market is studied across Non-Surgical Devices and Surgical Devices.
On the basis of Product, the Global Atrial Fibrillation Market is studied across Access Devices, Cardiac Monitors or Implantable Loop Recorder, EP Ablation Catheters, EP Diagnostic Catheter, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, and Mapping and Recording Systems.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Atrial Fibrillation Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Atrial Fibrillation Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Atrial Fibrillation Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Atrial Fibrillation Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Atrial Fibrillation Market
The report answers questions such as:
1. What is the market size of Atrial Fibrillation market in the Global?
2. What are the factors that affect the growth in the Global Atrial Fibrillation Market over the forecast period?
3. What is the competitive position in the Global Atrial Fibrillation Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Atrial Fibrillation Market?
5. What are the opportunities in the Global Atrial Fibrillation Market?
6. What are the modes of entering the Global Atrial Fibrillation Market?
The positioning of the Global Atrial Fibrillation Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Atrial Fibrillation Market including are Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, Acesion Pharma ApS, AFreeze GmbH, AuriGen Medical., BIOTRONIK SE & CO. KG, CardioFocus, Inc., Koninklijke Philips N.V, MicroPort Scientific Corp, Siemens AG, St. Jude Medical, Inc., and Stroke Foundation.
On the basis of Device, the Global Atrial Fibrillation Market is studied across Non-Surgical Devices and Surgical Devices.
On the basis of Product, the Global Atrial Fibrillation Market is studied across Access Devices, Cardiac Monitors or Implantable Loop Recorder, EP Ablation Catheters, EP Diagnostic Catheter, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, and Mapping and Recording Systems.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Atrial Fibrillation Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Atrial Fibrillation Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Atrial Fibrillation Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Atrial Fibrillation Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Atrial Fibrillation Market
The report answers questions such as:
1. What is the market size of Atrial Fibrillation market in the Global?
2. What are the factors that affect the growth in the Global Atrial Fibrillation Market over the forecast period?
3. What is the competitive position in the Global Atrial Fibrillation Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Atrial Fibrillation Market?
5. What are the opportunities in the Global Atrial Fibrillation Market?
6. What are the modes of entering the Global Atrial Fibrillation Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Atrial Fibrillation Market
3.2. Opportunities in the Atrial Fibrillation Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Rising prevalence of atrial fibrillation in geriatric population
4.2.1.2. Technology advancements in treatment and diagnostic methods to atrial fibrillation
4.2.2. Restraints
4.2.2.1. Dearth of skilled professionals
4.2.2.2. Elevated price of treatment
4.2.3. Opportunities
4.2.3.1. Increasing preference of catheter ablation for cardiac arrhythmia treatment
4.2.3.2. R&D activities to innovate new technologies for early detection and effective treatment methods.
4.2.4. Challenges
4.2.4.1. Unfavorable preference of pharmaceutical interventions (drugs) over AF treatment devices
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL ATRIAL FIBRILLATION MARKET, BY DEVICE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Non-Surgical Devices
5.3.1. Access Devices
5.3.2. Advanced Diagnostic Catheters
5.3.3. Cardiac Monitors
5.3.4. Conventional Diagnostic Catheters
5.3.4.1. Fixed Diagnostic Catheters
5.3.4.2. Steerable Diagnostic Catheters
5.3.5. Diagnostic Catheters
5.3.6. Electric Cardioversion
5.3.7. Intracardiac Echocardiography (ICE) Systems
5.3.8. Left Atrial Appendage and Closure Devices
5.3.9. Mapping and Recording Systems
5.4. Surgical Devices
5.4.1. Catheter Ablation
5.4.2. Cryoablation
5.4.3. Laser Based Catheter Ablation
5.4.4. Maze Surgery
5.4.5. Microwave Based Catheter Ablation
5.4.6. Navigational Advanced Mapping Accessories
5.4.7. Radiofrequency Catheter Ablation
5.4.7.1. Conventional RF Ablation Catheters
5.4.7.2. Irrigated-tip RF Ablation Catheters
6. GLOBAL ATRIAL FIBRILLATION MARKET, BY PRODUCT
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Access Devices
6.4. Cardiac Monitors or Implantable Loop Recorder
6.5. EP Ablation Catheters
6.6. EP Diagnostic Catheter
6.7. Intracardiac Echocardiography
6.8. Left Atrial Appendage Closure Devices
6.9. Mapping and Recording Systems
7. GLOBAL ATRIAL FIBRILLATION MARKET, BY GEOGRAPHY
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Americas
7.3.1. Overview
7.3.2. Market Sizing & Forecasting
7.3.3. Argentina
7.3.4. Brazil
7.3.5. Canada
7.3.6. Mexico
7.3.7. United States
7.4. Asia-Pacific
7.4.1. Overview
7.4.2. Market Sizing & Forecasting
7.4.3. Australia
7.4.4. China
7.4.5. India
7.4.6. Japan
7.5. Europe, Middle East & Africa
7.5.1. Overview
7.5.2. Market Sizing & Forecasting
7.5.3. France
7.5.4. Germany
7.5.5. Italy
7.5.6. Spain
7.5.7. United Kingdom
8. COMPETITIVE LANDSCAPE
8.1. 360iResearch FPNV Positioning Matrix for Global Atrial Fibrillation Market
8.2. Market Vendor Ranking Analysis for Global Atrial Fibrillation Market
8.3. Competitive News Feed Analysis for Global Atrial Fibrillation Market
9. COMPANY USABILITY PROFILES
9.1. Abbott Laboratories
9.1.1. Overview
9.1.2. Strategy
9.1.3. SWOT
9.2. AtriCure, Inc.
9.2.1. Overview
9.2.2. Strategy
9.2.3. SWOT
9.3. Boston Scientific Corporation
9.3.1. Overview
9.3.2. Strategy
9.3.3. SWOT
9.4. Johnson & Johnson
9.4.1. Overview
9.4.2. Strategy
9.4.3. SWOT
9.5. Medtronic plc
9.5.1. Overview
9.5.2. Strategy
9.5.3. SWOT
9.6. AFreeze GmbH
9.7. Acesion Pharma ApS
9.8. AuriGen Medical.
9.9. BIOTRONIK SE & CO. KG
9.10. CardioFocus, Inc.
9.11. Koninklijke Philips N.V
9.12. MicroPort Scientific Corp
9.13. Siemens AG
9.14. St. Jude Medical, Inc.
9.15. Stroke Foundation
10. APPENDIX
10.1. Discussion Guide
10.2. Top Reports
10.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Atrial Fibrillation Market
3.2. Opportunities in the Atrial Fibrillation Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Rising prevalence of atrial fibrillation in geriatric population
4.2.1.2. Technology advancements in treatment and diagnostic methods to atrial fibrillation
4.2.2. Restraints
4.2.2.1. Dearth of skilled professionals
4.2.2.2. Elevated price of treatment
4.2.3. Opportunities
4.2.3.1. Increasing preference of catheter ablation for cardiac arrhythmia treatment
4.2.3.2. R&D activities to innovate new technologies for early detection and effective treatment methods.
4.2.4. Challenges
4.2.4.1. Unfavorable preference of pharmaceutical interventions (drugs) over AF treatment devices
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL ATRIAL FIBRILLATION MARKET, BY DEVICE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Non-Surgical Devices
5.3.1. Access Devices
5.3.2. Advanced Diagnostic Catheters
5.3.3. Cardiac Monitors
5.3.4. Conventional Diagnostic Catheters
5.3.4.1. Fixed Diagnostic Catheters
5.3.4.2. Steerable Diagnostic Catheters
5.3.5. Diagnostic Catheters
5.3.6. Electric Cardioversion
5.3.7. Intracardiac Echocardiography (ICE) Systems
5.3.8. Left Atrial Appendage and Closure Devices
5.3.9. Mapping and Recording Systems
5.4. Surgical Devices
5.4.1. Catheter Ablation
5.4.2. Cryoablation
5.4.3. Laser Based Catheter Ablation
5.4.4. Maze Surgery
5.4.5. Microwave Based Catheter Ablation
5.4.6. Navigational Advanced Mapping Accessories
5.4.7. Radiofrequency Catheter Ablation
5.4.7.1. Conventional RF Ablation Catheters
5.4.7.2. Irrigated-tip RF Ablation Catheters
6. GLOBAL ATRIAL FIBRILLATION MARKET, BY PRODUCT
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Access Devices
6.4. Cardiac Monitors or Implantable Loop Recorder
6.5. EP Ablation Catheters
6.6. EP Diagnostic Catheter
6.7. Intracardiac Echocardiography
6.8. Left Atrial Appendage Closure Devices
6.9. Mapping and Recording Systems
7. GLOBAL ATRIAL FIBRILLATION MARKET, BY GEOGRAPHY
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Americas
7.3.1. Overview
7.3.2. Market Sizing & Forecasting
7.3.3. Argentina
7.3.4. Brazil
7.3.5. Canada
7.3.6. Mexico
7.3.7. United States
7.4. Asia-Pacific
7.4.1. Overview
7.4.2. Market Sizing & Forecasting
7.4.3. Australia
7.4.4. China
7.4.5. India
7.4.6. Japan
7.5. Europe, Middle East & Africa
7.5.1. Overview
7.5.2. Market Sizing & Forecasting
7.5.3. France
7.5.4. Germany
7.5.5. Italy
7.5.6. Spain
7.5.7. United Kingdom
8. COMPETITIVE LANDSCAPE
8.1. 360iResearch FPNV Positioning Matrix for Global Atrial Fibrillation Market
8.2. Market Vendor Ranking Analysis for Global Atrial Fibrillation Market
8.3. Competitive News Feed Analysis for Global Atrial Fibrillation Market
9. COMPANY USABILITY PROFILES
9.1. Abbott Laboratories
9.1.1. Overview
9.1.2. Strategy
9.1.3. SWOT
9.2. AtriCure, Inc.
9.2.1. Overview
9.2.2. Strategy
9.2.3. SWOT
9.3. Boston Scientific Corporation
9.3.1. Overview
9.3.2. Strategy
9.3.3. SWOT
9.4. Johnson & Johnson
9.4.1. Overview
9.4.2. Strategy
9.4.3. SWOT
9.5. Medtronic plc
9.5.1. Overview
9.5.2. Strategy
9.5.3. SWOT
9.6. AFreeze GmbH
9.7. Acesion Pharma ApS
9.8. AuriGen Medical.
9.9. BIOTRONIK SE & CO. KG
9.10. CardioFocus, Inc.
9.11. Koninklijke Philips N.V
9.12. MicroPort Scientific Corp
9.13. Siemens AG
9.14. St. Jude Medical, Inc.
9.15. Stroke Foundation
10. APPENDIX
10.1. Discussion Guide
10.2. Top Reports
10.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.3. Author Details
